Ten63 Therapeutics
Bruce is a leader in computational protein and drug design, and a world expert in the design of therapeutics that are resilient to drug resistance. His many accomplishments include the novel design of a picomolar inhibitor of HIV protease that was resilient to all main resistance mutations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ten63 Therapeutics
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.